Cough, fever, and weight loss: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| ! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;...")
 
No edit summary
 
Line 1: Line 1:
__NOTOC__
{{CMG}}; {{AE}} {{KZ}}, {{Anmol}}
==Cough, fever, and Weight loss differential diagnosis==
{|
{|
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" colspan="2" + |Organ system
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Diseases
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="8" + |Clinical manifestations
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="2" colspan="4" + |Diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Other features
|-
|-
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="7" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
|-
Line 49: Line 55:
*Phases: Catarrhal, paroxysmal and convalescent
*Phases: Catarrhal, paroxysmal and convalescent
|-
|-
| rowspan="5" align="center" style="background:#DCDCDC;" + |[[Respiratory system|'''Respiratory''']]
| align="center" style="background:#DCDCDC;" rowspan="4" + |[[Respiratory system|'''Respiratory''']]
| rowspan="5" align="center" style="background:#DCDCDC;" + |[[Parenchyma|'''Parenchyma''']]
| align="center" style="background:#DCDCDC;" rowspan="4" + |[[Parenchyma|'''Parenchyma''']]
| align="center" style="background:#DCDCDC;" + |[[Pneumoconiosis|'''Pneumoconioses''']]<ref name="pmid27980247">{{cite journal |vauthors=Jp NA, Imanaka M, Suganuma N |title=Japanese workplace health management in pneumoconiosis prevention |journal=J Occup Health |volume=59 |issue=2 |pages=91–103 |year=2017 |pmid=27980247 |pmc=5478517 |doi=10.1539/joh.16-0031-RA |url=}}</ref><ref name="pmid12668748">{{cite journal |vauthors=Weiland DA, Lynch DA, Jensen SP, Newell JD, Miller DE, Crausman RS, Kuhn C, Kern DG |title=Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease |journal=Radiology |volume=227 |issue=1 |pages=222–31 |year=2003 |pmid=12668748 |doi=10.1148/radiol.2271011063 |url=}}</ref>
| align="center" style="background:#DCDCDC;" + |[[Pneumoconiosis|'''Pneumoconioses''']]<ref name="pmid27980247">{{cite journal |vauthors=Jp NA, Imanaka M, Suganuma N |title=Japanese workplace health management in pneumoconiosis prevention |journal=J Occup Health |volume=59 |issue=2 |pages=91–103 |year=2017 |pmid=27980247 |pmc=5478517 |doi=10.1539/joh.16-0031-RA |url=}}</ref><ref name="pmid12668748">{{cite journal |vauthors=Weiland DA, Lynch DA, Jensen SP, Newell JD, Miller DE, Crausman RS, Kuhn C, Kern DG |title=Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease |journal=Radiology |volume=227 |issue=1 |pages=222–31 |year=2003 |pmid=12668748 |doi=10.1148/radiol.2271011063 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Acute, Chronic
| align="center" style="background:#F5F5F5;" + |Acute, Chronic
Line 110: Line 116:
**[[Small cell lung cancer|Small cell lung cance]]<nowiki/>r ([[Small cell lung cancer|SCLC]])
**[[Small cell lung cancer|Small cell lung cance]]<nowiki/>r ([[Small cell lung cancer|SCLC]])
**[[Non small cell lung cancer|Non−small cell lung cance]]<nowiki/>r ([[Non small cell lung cancer|NSCLC]])
**[[Non small cell lung cancer|Non−small cell lung cance]]<nowiki/>r ([[Non small cell lung cancer|NSCLC]])
|-
| align="center" style="background:#DCDCDC;" + |'''[[Interstitial lung disease]]'''<ref name="pmid15331185">{{cite journal |vauthors=Lama VN, Martinez FJ |title=Resting and exercise physiology in interstitial lung diseases |journal=Clin. Chest Med. |volume=25 |issue=3 |pages=435–53, v |year=2004 |pmid=15331185 |doi=10.1016/j.ccm.2004.05.005 |url=}}</ref><ref name="pmid15133338">{{cite journal |vauthors=Chetta A, Marangio E, Olivieri D |title=Pulmonary function testing in interstitial lung diseases |journal=Respiration |volume=71 |issue=3 |pages=209–13 |year=2004 |pmid=15133338 |doi=10.1159/000077416 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Variable
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*[[Rales|Crackles]] or velcro rales
*[[Lung volumes|Inspiratory]] high−pitched [[rhonchi]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Hepatic function test]]
*[[Renal function tests|Renal function test]]
*[[Complete blood count|CBC]]
*[[Serology|Serological testing]]
| style="background:#F5F5F5;" + |
*[[Nodular]], [[reticular]] or both pattern in [[Chest X-ray|chest X−ray]]
*[[Computed tomography|CT]] in patients with diffuse pulmonary lung disease
| style="background:#F5F5F5;" + |
*Reduction in [[Vital capacity|FVC]], [[Residual volume|RV]], [[Functional residual capacity|FRC]], [[Total lung capacity|TLC]] and [[FEV1]] on spirometry
*[[FEV1/FVC ratio|FEV1/FVC]] normal or increase
*[[Lung volumes]]
*Diffusion capacity ([[DLCO]] reduced)
| style="background:#F5F5F5;" + |
*Lung [[biopsy]] when lab, imaging, and PFT has indeterminate result
| style="background:#F5F5F5;" + |
*Clubbing is common in [[asbestosis]] and [[idiopathic pulmonary fibrosis]]
|-
|-
| align="center" style="background:#DCDCDC;" + |'''[[Tuberculosis]] ([[Tuberculosis|TB]])'''<ref name="pmid9332519">{{cite journal |vauthors=Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R |title=Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) |journal=Clin. Infect. Dis. |volume=25 |issue=2 |pages=242–6 |year=1997 |pmid=9332519 |doi= |url=}}</ref><ref name="pmid2456183">{{cite journal |vauthors=Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD |title=Chest roentgenogram in pulmonary tuberculosis. New data on an old test |journal=Chest |volume=94 |issue=2 |pages=316–20 |year=1988 |pmid=2456183 |doi= |url=}}</ref>
| align="center" style="background:#DCDCDC;" + |'''[[Tuberculosis]] ([[Tuberculosis|TB]])'''<ref name="pmid9332519">{{cite journal |vauthors=Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R |title=Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) |journal=Clin. Infect. Dis. |volume=25 |issue=2 |pages=242–6 |year=1997 |pmid=9332519 |doi= |url=}}</ref><ref name="pmid2456183">{{cite journal |vauthors=Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD |title=Chest roentgenogram in pulmonary tuberculosis. New data on an old test |journal=Chest |volume=94 |issue=2 |pages=316–20 |year=1988 |pmid=2456183 |doi= |url=}}</ref>
Line 207: Line 182:
*Evidence of [[Cystic fibrosis transmembrane conductance regulator|CFTR]] dysfunction
*Evidence of [[Cystic fibrosis transmembrane conductance regulator|CFTR]] dysfunction
|-
|-
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" colspan="2" + |Organ system
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Diseases
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="8" + |Clinical manifestations
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="2" colspan="4" + |Diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Other features
|-
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Onset
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Duration
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Productive cough
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Weight lost
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ascultation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PFT
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
| colspan="2" rowspan="2" align="center" style="background:#DCDCDC;" + |[[Heart|'''Cardiac''']]
| align="center" style="background:#DCDCDC;" + |[[Pulmonary edema|'''Cardiogenic pulmonary edema''']]<ref name="pmid16365214">{{cite journal |vauthors=Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L |title=Acute heart failure syndromes: current state and framework for future research |journal=Circulation |volume=112 |issue=25 |pages=3958–68 |year=2005 |pmid=16365214 |doi=10.1161/CIRCULATIONAHA.105.590091 |url=}}</ref><ref name="pmid23741058">{{cite journal |vauthors=Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL |title=2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines |journal=Circulation |volume=128 |issue=16 |pages=e240–327 |year=2013 |pmid=23741058 |doi=10.1161/CIR.0b013e31829e8776 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Acute
| style="background:#F5F5F5;" + |
*Days to weeks
| align="center" style="background:#F5F5F5;" + | + Pink frothy, liquid
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Rales|Crackles]]
*Increased [[respiratory rate]]
*[[Wheeze|Wheezing]]
*[[Rhonchi]]
*Gurgling sounds
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Arterial blood gas]]
*[[Blood urea nitrogen|BUN]]
*[[Serum creatinine|Serum creatinin]]
*Serum [[troponin]]
*[[Electrolyte|Electrolytes]]
*[[Lactic acid]]
*[[Complete blood count]]
| style="background:#F5F5F5;" + |
*[[Cardiomegaly]], [[pleural effusion]], interstitial [[edema]], alveolar [[edema]] and blood redistribution in lower lobes in [[Chest X-ray|chest X−ray]]
| style="background:#F5F5F5;" + |
*Not specific
| style="background:#F5F5F5;" + |
*Clinical diagnosis
*Tests are supportive
| style="background:#F5F5F5;" + |
*[[12-lead ECG|12−lead ECG]]
*Plasma [[Brain natriuretic peptide|BNP]] and [[NT-proBNP|NT−proBNP]]
*[[Echocardiography]]
|-
| align="center" style="background:#DCDCDC;" + |[[Pulmonary hypertension|'''Pulmonary hypertension''']]<ref name="pmid21393391">{{cite journal |vauthors=Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG |title=Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry |journal=Chest |volume=140 |issue=1 |pages=19–26 |year=2011 |pmid=21393391 |pmc=3198486 |doi=10.1378/chest.10-1166 |url=}}</ref><ref name="pmid12651053">{{cite journal| author=Sun XG, Hansen JE, Oudiz RJ, Wasserman K| title=Pulmonary function in primary pulmonary hypertension. | journal=J Am Coll Cardiol | year= 2003 | volume= 41 | issue= 6 | pages= 1028-35 | pmid=12651053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12651053  }}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*More than 2 years
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Dysphonia|Hoarseness]]
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Human Immunodeficiency Virus (HIV)|HIV]] serology
*[[Anti-nuclear antibody|Antinuclear antibody]] ([[Antinuclear antibodies|ANA]])
*[[Rheumatoid factor]] ([[RF]])
*[[Anti-neutrophil cytoplasmic antibody|Anti−neutrophil  cytoplasmic antibody]] ([[Anti-neutrophil cytoplasmic antibody|ANCA]])
| style="background:#F5F5F5;" + |
*Enlargement of the central [[pulmonary artery]] and right heart  in [[Chest X-ray|chest X−Ray]]
*[[Pulmonary  artery]] systolic pressure can be estimated in [[echocardiography]]
| style="background:#F5F5F5;" + |
*Low levels of [[FEV1]]
*Decreased [[Vital capacity|FVC]]
*[[DLCO]] reduced
| style="background:#F5F5F5;" + |
*Mean [[pulmonary artery]] pressure more than 25 [[mmHg]] at rest
| style="background:#F5F5F5;" + |
*[[Chest pain]]
*[[Ascites]]
*[[Syncope]]
*Peripherial [[edema]]
|-
| colspan="2" align="center" style="background:#DCDCDC;" + |[[Gastrointestinal tract|'''Gastrointestinal''']]
| align="center" style="background:#DCDCDC;" + |[[Gastroesophageal reflux disease|'''Gastroesophageal reflux''']]<ref name="pmid21508423">{{cite journal |vauthors=Kahrilas PJ, Hughes N, Howden CW |title=Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease |journal=Gut |volume=60 |issue=11 |pages=1473–8 |year=2011 |pmid=21508423 |doi=10.1136/gut.2011.241307 |url=}}</ref><ref name="pmid25133039">{{cite journal| author=Badillo R, Francis D| title=Diagnosis and treatment of gastroesophageal reflux disease. | journal=World J Gastrointest Pharmacol Ther | year= 2014 | volume= 5 | issue= 3 | pages= 105-12 | pmid=25133039 | doi=10.4292/wjgpt.v5.i3.105 | pmc=4133436 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25133039  }}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Variable
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*[[Hoarseness]]
| style="background:#F5F5F5;" + |
*Not specific
| style="background:#F5F5F5;" + |
*[[Upper endoscopy]] may be helpful
*[[Barium]] esophagram may be helpful
| style="background:#F5F5F5;" + |
*Normal function
| style="background:#F5F5F5;" + |
*PH testing
| align="center" style="background:#F5F5F5;" + |−−
|-
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features
|-
|-
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="7" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
|-
Line 342: Line 204:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
|-
| colspan="2" rowspan="4" align="center" style="background:#DCDCDC;" + |'''[[Autoimmune]]'''
| align="center" style="background:#DCDCDC;" rowspan="4" colspan="2" + |'''[[Autoimmune]]'''
| align="center" style="background:#DCDCDC;" + |[[Granulomatosis with polyangiitis|'''Wegener's disease''']] ([[Granulomatosis with polyangiitis|'''GPA''']]) <ref name="pmid1739240">{{cite journal |vauthors=Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS |title=Wegener granulomatosis: an analysis of 158 patients |journal=Ann. Intern. Med. |volume=116 |issue=6 |pages=488–98 |year=1992 |pmid=1739240 |doi= |url=}}</ref><ref name="pmid21374588">{{cite journal |vauthors=Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA |title=Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis |journal=Arthritis Rheum. |volume=63 |issue=4 |pages=863–4 |year=2011 |pmid=21374588 |doi=10.1002/art.30286 |url=}}</ref>
| align="center" style="background:#DCDCDC;" + |[[Granulomatosis with polyangiitis|'''Wegener's disease''']] ([[Granulomatosis with polyangiitis|'''GPA''']]) <ref name="pmid1739240">{{cite journal |vauthors=Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS |title=Wegener granulomatosis: an analysis of 158 patients |journal=Ann. Intern. Med. |volume=116 |issue=6 |pages=488–98 |year=1992 |pmid=1739240 |doi= |url=}}</ref><ref name="pmid21374588">{{cite journal |vauthors=Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA |title=Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis |journal=Arthritis Rheum. |volume=63 |issue=4 |pages=863–4 |year=2011 |pmid=21374588 |doi=10.1002/art.30286 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| align="center" style="background:#F5F5F5;" + |Chronic

Latest revision as of 22:47, 10 March 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karina Zavaleta, MD [2], Anmol Pitliya, M.B.B.S. M.D.[3]

Cough, fever, and Weight loss differential diagnosis

Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Respiratory Upper airway diseases Pertussis[1][2] Acute
  • Two weeks
+ Whooping sound + + +
  • Clear chest
  • Normal function
  • Culture
Respiratory Parenchyma Pneumoconioses[3][4] Acute, Chronic
  • Years
+ + +
Lung cancer[5][6] Chronic
  • Years
+ + + +/− + The following investigations may be helpful:
  • Not specific
Tuberculosis (TB)[7][8] Chronic
  • More than 2 or 3 weeks
+ + + + +
Cystic fibrosis (CF)[9][10] Chronic
  • Variable
+ + +/− +
  • Evidence of CFTR dysfunction
Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Autoimmune Wegener's disease (GPA) [11][12] Chronic
  • Months
+ + + + + The following investigations may be helpful:
Sarcoidosis[13][14] Chronic
  • Years
+ + + The following investigations may be helpful:
Microscopic polyangitis (MPA)[15] Chronic
  • Variable
+ + + + + The following investigations may be helpful:
Churg−Strauss[16][17] Chronic
  • Variable
+ + + + +
  • Infiltrates in chest X−Ray
  • Ground glass opacities, tree−in−bud sign and small nodules in chest CT

References

  1. Bellamy EA, Johnston ID, Wilson AG (1987). "The chest radiograph in whooping cough". Clin Radiol. 38 (1): 39–43. PMID 3816065.
  2. "Pertussis | Whooping Cough | Clinical | Information | CDC".
  3. Jp NA, Imanaka M, Suganuma N (2017). "Japanese workplace health management in pneumoconiosis prevention". J Occup Health. 59 (2): 91–103. doi:10.1539/joh.16-0031-RA. PMC 5478517. PMID 27980247.
  4. Weiland DA, Lynch DA, Jensen SP, Newell JD, Miller DE, Crausman RS, Kuhn C, Kern DG (2003). "Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease". Radiology. 227 (1): 222–31. doi:10.1148/radiol.2271011063. PMID 12668748.
  5. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). "Global cancer statistics". CA Cancer J Clin. 61 (2): 69–90. doi:10.3322/caac.20107. PMID 21296855.
  6. Ost DE, Jim Yeung SC, Tanoue LT, Gould MK (2013). "Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines". Chest. 143 (5 Suppl): e121S–e141S. doi:10.1378/chest.12-2352. PMC 4694609. PMID 23649435.
  7. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R (1997). "Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG)". Clin. Infect. Dis. 25 (2): 242–6. PMID 9332519.
  8. Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD (1988). "Chest roentgenogram in pulmonary tuberculosis. New data on an old test". Chest. 94 (2): 316–20. PMID 2456183.
  9. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW (2008). "Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report". J. Pediatr. 153 (2): S4–S14. doi:10.1016/j.jpeds.2008.05.005. PMC 2810958. PMID 18639722.
  10. Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992). "Prediction of mortality in patients with cystic fibrosis". N. Engl. J. Med. 326 (18): 1187–91. doi:10.1056/NEJM199204303261804. PMID 1285737.
  11. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992). "Wegener granulomatosis: an analysis of 158 patients". Ann. Intern. Med. 116 (6): 488–98. PMID 1739240.
  12. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA (2011). "Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis". Arthritis Rheum. 63 (4): 863–4. doi:10.1002/art.30286. PMID 21374588.
  13. Carmona EM, Kalra S, Ryu JH (2016). "Pulmonary Sarcoidosis: Diagnosis and Treatment". Mayo Clin. Proc. 91 (7): 946–54. doi:10.1016/j.mayocp.2016.03.004. PMID 27378039.
  14. Yanardağ H, Pamuk GE, Karayel T, Demirci S (2002). "Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples". Haematologia (Budap). 32 (4): 419–25. PMID 12803116.
  15. Jennette, J. Charles; Falk, Ronald J. (1997). "Small-Vessel Vasculitis". New England Journal of Medicine. 337 (21): 1512–1523. doi:10.1056/NEJM199711203372106. ISSN 0028-4793.
  16. Vaglio A, Buzio C, Zwerina J (2013). "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art". Allergy. 68 (3): 261–73. doi:10.1111/all.12088. PMID 23330816.
  17. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984). "Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome". Medicine (Baltimore). 63 (2): 65–81. PMID 6366453.